イマチニブはある種のがんの治療に使用され、チロシンキナーゼ阻害薬（TKI）として知られる薬剤のクラスに属します。イマチニブは、特定のがん細胞によって産生されるチロシンキナーゼと呼ばれる異常なタンパク質を特異的に標的とし、その活性を阻害します。イマチニブは主に、異常な白血球の過剰産生を特徴とする血液がんの一種である慢性骨髄性白血病（CML）の治療に用いられます。また、消化管に発生する腫瘍の一種である消化管間質腫瘍（GIST）の治療にも処方されることがあります。イマチニブ医薬品市場は、慢性骨髄性白血病（CML）や消化管間質腫瘍（GIST）の発生率の増加、標的薬物療法に対する需要の増加などの要因により拡大しています。
イマチニブは慢性骨髄性白血病（CML）の治療で顕著な成功を収め、高い奏効率と長期予後の改善につながっています。したがって、慢性骨髄性白血病（CML）の罹患率の増加が市場成長の原動力となっています。National Library of Medicineによると、世界中の慢性骨髄性白血病（CML）の有病率は2020年には112,000人であり、2030年には144,000人、2040年には167,000人、2050年には181,000人に増加すると予測されています。世界中で慢性骨髄性白血病（CML）の罹患率が上昇していることが、市場成長の推進力となっています。さらに、ヘルスケア支出の増加とイマチニブ医薬品開発に関連する研究開発活動の活発化が、市場に有利な機会を生み出しています。しかし、イマチニブ医薬品のコストの高さと代替品の入手可能性が、2023年から2030年の予測期間を通じて市場の成長を阻害しています。
世界のイマチニブ医薬品市場調査の対象となる主要地域には、アジア太平洋、北アメリカ、ヨーロッパ、ラテンアメリカ、中東・アフリカが含まれます。北アメリカは、主要市場プレイヤーの存在、薬剤の新興市場開拓、同地域におけるがん疾患の罹患率の上昇により、2022年の市場を独占しました。一方、アジア太平洋地域は、同地域におけるがんの罹患率の上昇、創薬活動への投資の増加、創薬活動を促進するための政府のイニシアチブの高まりなどの要因により、著しい成長を示しています。
この調査の目的は、近年のさまざまなセグメントおよび国の市場規模を定義し、今後数年間の市場規模を予測することです。この報告書は、調査に参加している国の業界の定性的および定量的側面の両方を組み込むように設計されています。
このレポートは、市場の将来の成長を定義する推進要因や課題などの重要な側面に関する詳細情報も提供します。さらに、競争環境と主要企業の製品提供の詳細な分析とともに、利害関係者が投資できるミクロ市場における潜在的な機会も組み込まれています。
目次
Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Imatinib Drug Market, by Region, 2020-2030 (USD Billion)
1.2.2. Imatinib Drug Market, by Drug Formulation, 2020-2030 (USD Billion)
1.2.3. Imatinib Drug Market, by Application Type, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Imatinib Drug Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Imatinib Drug Market Dynamics
3.1. Imatinib Drug Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing incidence of chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GISTs)
3.1.1.2. Increase in demand for target drug therapy.
3.1.2. Market Challenges
3.1.2.1. High Cost of Imatinib Drug
3.1.2.2. Availability of substitutes
3.1.3. Market Opportunities
3.1.3.1. Rise in healthcare expenditure
3.1.3.2. Increasing R&D activities related to imatinib.
Chapter 4. Global Imatinib Drug Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter's 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Imatinib Drug Market, by Drug Formulation
5.1. Market Snapshot
5.2. Global Imatinib Drug Market by Drug Formulation, Performance - Potential Analysis
5.3. Global Imatinib Drug Market Estimates & Forecasts by Drug Formulation 2020-2030 (USD Billion)
5.4. Imatinib Drug Market, Sub Segment Analysis
5.4.1. Capsules
5.4.2. Tablets
Chapter 6. Global Imatinib Drug Market, by Application Type
6.1. Market Snapshot
6.2. Global Imatinib Drug Market by Application Type, Performance - Potential Analysis
6.3. Global Imatinib Drug Market Estimates & Forecasts by Application Type 2020-2030 (USD Billion)
6.4. Imatinib Drug Market, Sub Segment Analysis
6.4.1. Philadelphia Positive Chronic Myeloid Leukemia
6.4.2. Hyper-Eosinophilic Syndrome (HES)
6.4.3. Myelodysplastic Syndrome (MDS)
6.4.4. Myeloproliferative Diseases (MPD)
6.4.5. Gastrointestinal Stromal Tumors (GIST)
6.4.6. Others
Chapter 7. Global Imatinib Drug Market, Regional Analysis
7.1. Top Leading Countries
7.2. Top Emerging Countries
7.3. Imatinib Drug Market, Regional Market Snapshot
7.4. North America Imatinib Drug Market
7.4.1. U.S. Imatinib Drug Market
7.4.1.1. Drug Formulation breakdown estimates & forecasts, 2020-2030
7.4.1.2. Application Type breakdown estimates & forecasts, 2020-2030
7.4.2. Canada Imatinib Drug Market
7.5. Europe Imatinib Drug Market Snapshot
7.5.1. U.K. Imatinib Drug Market
7.5.2. Germany Imatinib Drug Market
7.5.3. France Imatinib Drug Market
7.5.4. Spain Imatinib Drug Market
7.5.5. Italy Imatinib Drug Market
7.5.6. Rest of Europe Imatinib Drug Market
7.6. Asia-Pacific Imatinib Drug Market Snapshot
7.6.1. China Imatinib Drug Market
7.6.2. India Imatinib Drug Market
7.6.3. Japan Imatinib Drug Market
7.6.4. Australia Imatinib Drug Market
7.6.5. South Korea Imatinib Drug Market
7.6.6. Rest of Asia Pacific Imatinib Drug Market
7.7. Latin America Imatinib Drug Market Snapshot
7.7.1. Brazil Imatinib Drug Market
7.7.2. Mexico Imatinib Drug Market
7.8. Middle East & Africa Imatinib Drug Market
7.8.1. Saudi Arabia Imatinib Drug Market
7.8.2. South Africa Imatinib Drug Market
7.8.3. Rest of Middle East & Africa Imatinib Drug Market
Chapter 8. Competitive Intelligence
8.1. Key Company SWOT Analysis
8.1.1. Company 1
8.1.2. Company 2
8.1.3. Company 3
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Sun Pharmaceutical Industries Ltd.
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Recent Developments
8.3.2. Novartis AG
8.3.3. Dr. Reddy's Laboratories Ltd
8.3.4. Teva Pharmaceutical Industries Ltd.
8.3.5. Mylan N.V.
8.3.6. Cipla Inc
8.3.7. Apotex Inc
8.3.8. Sanofi S.A
8.3.9. Glenmark Pharmaceuticals Ltd.
8.3.10. Dongbao Pharmaceutical Co. Ltd.
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Imatinib Drug Market, report scope
TABLE 2. Global Imatinib Drug Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Imatinib Drug Market estimates & forecasts by Drug Formulation 2020-2030 (USD Billion)
TABLE 4. Global Imatinib Drug Market estimates & forecasts by Application Type 2020-2030 (USD Billion)
TABLE 5. Global Imatinib Drug Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 6. Global Imatinib Drug Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global Imatinib Drug Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Imatinib Drug Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Imatinib Drug Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Imatinib Drug Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Imatinib Drug Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Imatinib Drug Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Imatinib Drug Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Imatinib Drug Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. U.S. Imatinib Drug Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. U.S. Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 17. U.S. Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18. Canada Imatinib Drug Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 19. Canada Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 20. Canada Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. UK Imatinib Drug Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 22. UK Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 23. UK Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. Germany Imatinib Drug Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 25. Germany Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 26. Germany Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. France Imatinib Drug Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 28. France Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 29. France Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. Italy Imatinib Drug Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 31. Italy Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 32. Italy Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Spain Imatinib Drug Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 34. Spain Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 35. Spain Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. RoE Imatinib Drug Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 37. RoE Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 38. RoE Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. China Imatinib Drug Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 40. China Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 41. China Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. India Imatinib Drug Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 43. India Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 44. India Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. Japan Imatinib Drug Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 46. Japan Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 47. Japan Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. South Korea Imatinib Drug Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 49. South Korea Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 50. South Korea Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. Australia Imatinib Drug Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 52. Australia Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 53. Australia Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. RoAPAC Imatinib Drug Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 55. RoAPAC Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 56. RoAPAC Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. Brazil Imatinib Drug Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 58. Brazil Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 59. Brazil Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Mexico Imatinib Drug Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 61. Mexico Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 62. Mexico Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. RoLA Imatinib Drug Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 64. RoLA Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 65. RoLA Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. Saudi Arabia Imatinib Drug Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 67. South Africa Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 68. RoMEA Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. List of secondary sources, used in the study of global Imatinib Drug Market
TABLE 70. List of primary sources, used in the study of global Imatinib Drug Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
FIG 1. Global Imatinib Drug Market, research methodology
FIG 2. Global Imatinib Drug Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Imatinib Drug Market, key trends 2022
FIG 5. Global Imatinib Drug Market, growth prospects 2023-2030
FIG 6. Global Imatinib Drug Market, porters 5 force model
FIG 7. Global Imatinib Drug Market, pest analysis
FIG 8. Global Imatinib Drug Market, value chain analysis
FIG 9. Global Imatinib Drug Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Imatinib Drug Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Imatinib Drug Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Imatinib Drug Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Imatinib Drug Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Imatinib Drug Market, regional snapshot 2020 & 2030
FIG 15. North America Imatinib Drug Market 2020 & 2030 (USD Billion)
FIG 16. Europe Imatinib Drug Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Imatinib Drug Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Imatinib Drug Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Imatinib Drug Market 2020 & 2030 (USD Billion)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
